{"id":5170,"date":"2020-10-11T21:34:25","date_gmt":"2020-10-11T19:34:25","guid":{"rendered":"https:\/\/golivertx.com\/?p=5170"},"modified":"2021-03-19T21:59:57","modified_gmt":"2021-03-19T20:59:57","slug":"news-about-golivertx","status":"publish","type":"post","link":"https:\/\/golivertx.com\/news-about-golivertx\/?lang=en","title":{"rendered":"News about GoliverTX"},"content":{"rendered":"<p>03\/2021: GOLIVER THERAPEUTICS IS THE WINNER OF THE FRENCH GOVERNMENT\u2019S \u00ab RECOVERY PLAN FOR INDUSTRY &#8211; STRATEGIC SECTORS \u00bb CALL FOR THE IMPLEMENTATION OF\u00a0 ITS INDUSTRIAL MANUFACTURING PLATFORM PROJECT AIMED AT\u00a0 DEVELOPING BIOMEDICINE FROM PLURIPOTENT STEM CELLS<\/p>\n<p>\u279e <a href=\"https:\/\/golivertx.com\/wp-content\/uploads\/2021\/03\/GoLiver_CP_Subvention_France_Relance_20210318-EN.pdf\" target=\"_blank\" rel=\"noopener\">Press communication : GoLiver_CP_Subvention_France_Relance_20210318 EN.pdf<\/a><\/p>\n<p><u>\u279e <a href=\"https:\/\/www.latribune.fr\/entreprises-finance\/industrie\/chimie-pharmacie\/therapie-cellulaire-goliver-therapeutics-sur-les-traces-de-l-arn-messager-880289.html\">https:\/\/www.latribune.fr\/entreprises-finance\/industrie\/chimie-pharmacie\/therapie-cellulaire-goliver-therapeutics-sur-les-traces-de-l-arn-messager-880289.html<\/a><\/u><\/p>\n<p>\u279e <a href=\"https:\/\/www.lesechos.fr\/pme-regions\/innovateurs\/goliver-parie-sur-les-cellules-souches-pour-reparer-le-foie-1299316\">https:\/\/www.lesechos.fr\/pme-regions\/innovateurs\/goliver-parie-sur-les-cellules-souches-pour-reparer-le-foie-1299316<\/a><\/p>\n<p>\u279e <a href=\"https:\/\/nantes.maville.com\/actu\/actudet_--medecine-regenerative-un-nouveau-pas-de-geant-pour-la-start-up-nantaise-goliver-_fil-4544852_actu.Htm\">https:\/\/nantes.maville.com\/actu\/actudet_&#8211;medecine-regenerative-un-nouveau-pas-de-geant-pour-la-start-up-nantaise-goliver-_fil-4544852_actu.Htm<\/a><\/p>\n<p>\u279e<a href=\"https:\/\/biotechinfo.fr\/article\/goliver-therapeutics-obtient-un-avis-scientifique-positif-de-lagence-europeenne-du-medicament-ema-sur-sa-strategie-de-developpement-clinique-et-de-bioproduction-dans-linsuffisance\/\"> https:\/\/biotechinfo.fr\/article\/goliver-therapeutics-obtient-un-avis-scientifique-positif-de-lagence-europeenne-du-medicament-ema-sur-sa-strategie-de-developpement-clinique-et-de-bioproduction-dans-linsuffisance\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>11\/2020: GoLiver Therapeutics\u00a0is awarded with <b>Seal of Excellence Certificate by the European Commission <\/b>in Horizon H2020-EIC accelerator. After only 3 years of creation, it shows the significance of our project (Excellence, Impact, and Implementation criteria) at the EU level and provides a new guarantee of the quality and potential of our company with its current and future investors, public and private funders, and other stakeholders. Thanks very much to all the liver transplant centers, Pharma companies, Public institutions, and Patient associations that give us a letter of interest, and congrats to the beautiful team!<\/p>\n<p>\u279e <a href=\"https:\/\/golivertx.com\/wp-content\/uploads\/2020\/10\/Seal-of-Excellence-Certificate-by-the-European-Commission-.jpg\">https:\/\/golivertx.com\/wp-content\/uploads\/2020\/10\/Seal-of-Excellence-Certificate-by-the-European-Commission-.jpg<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>06\/2020: GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicine Agency (EMA) on its Clinical Development and Biomanufacturing Strategy for Acute Liver Failure<br \/>\n\u279e <a href=\"https:\/\/www.businesswire.com\/news\/home\/20200629005030\/en\/GoLiver-Therapeutics-Receives-a-Positive-Scientific-Advice-from-the-European-Medicines-Agency-EMA-on-its-Clinical-Development-and-Biomanufacturing-Strategy-for-Acute-Liver-Failure\">https:\/\/www.businesswire.com\/news\/home\/20200629005030\/en\/GoLiver-Therapeutics-Receives-a-Positive-Scientific-Advice-from-the-European-Medicines-Agency-EMA-on-its-Clinical-Development-and-Biomanufacturing-Strategy-for-Acute-Liver-Failure<\/a><br \/>\n\u279e GoLiver Therapeutics Receives \u6025\u6027\u809d\u4e0d\u5168\u306b\u5bfe\u3059\u308b\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30d0\u30a4\u30aa\u88fd\u9020\u6226\u7565\u306b\u3064\u304d\u6b27\u5dde\u533b\u85ac\u54c1\u5e81\uff08EMA\uff09\u3088\u308a\u80af\u5b9a\u7684\u306a\u79d1\u5b66\u7684\u52e7\u544a\u3092\u53d7\u9818 (<a href=\"http:\/\/www.qlifepro.com\/press\/20200630-10-56654\/goliver-therapeutics\/\">http:\/\/www.qlifepro.com\/press\/20200630-10-56654\/goliver-therapeutics\/<\/a>)<\/p>\n<p>&nbsp;<\/p>\n<p>12\/2019: GoLiver Therapeutics and AP-HP signed a partnership agreement for preparing a phase 1-2a clinical trial for the treatment of sever fulminant liver diseases<br \/>\n\u279e<a href=\"https:\/\/www.atlanpole.fr\/wp-content\/uploads\/2019\/12\/CP_GoLiver_20191205_VDEF.pdf\">https:\/\/www.atlanpole.fr\/wp-content\/uploads\/2019\/12\/CP_GoLiver_20191205_VDEF.pdf<\/a><br \/>\n\u279e<a href=\"https:\/\/www.thepharmaletter.com\/article\/goliver-seeks-regenerative-alternative-to-liver-transplantation\">https:\/\/www.thepharmaletter.com\/article\/goliver-seeks-regenerative-alternative-to-liver-transplantation<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>12\/2019: Le Monde News. Dans les biotechnologies et la sant\u00e9, le \u00ab jeu \u00e0 la nantaise \u00bb fait \u00e9clore des p\u00e9pites.<br \/>\n\u279e <a href=\"https:\/\/www.lemonde.fr\/campus\/article\/2019\/12\/14\/dans-les-biotechnologies-et-la-sante-le-jeu-a-la-nantaise-fait-eclore-des-pepites_6022843_4401467.html\">https:\/\/www.lemonde.fr\/campus\/article\/2019\/12\/14\/dans-les-biotechnologies-et-la-sante-le-jeu-a-la-nantaise-fait-eclore-des-pepites_6022843_4401467.html<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>09\/2019: \u00ab French Tech Seed \u00bb winner (Bpifrance DeepTech)<br \/>\n\u279e<a href=\"https:\/\/www.atlanpole.fr\/actualites\/le-consortium-french-tech-seed-pays-de-la-loire-labellise\/\">https:\/\/www.atlanpole.fr\/actualites\/le-consortium-french-tech-seed-pays-de-la-loire-labellise\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>07\/2019: Published paper. Fourrier A et al. Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent stem cells-derived hepatic stem cells. Xenotransplantation. 2020 Jan;27(1):e12544.<br \/>\n\u279e<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31342573\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31342573\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>03\/2019: GoLiver Therapeutics identified as one of the 100 start-ups where to invest by the Challenges Magazine<br \/>\n\u279e <a href=\"https:\/\/www.challenges.fr\/classements\/start-up\/2019\/\">https:\/\/www.challenges.fr\/classements\/start-up\/2019\/<\/a><br \/>\n\u279e <a href=\"https:\/\/www.challenges.fr\/start-up\/goliver-reparer-le-foie-sans-greffe_648605\">https:\/\/www.challenges.fr\/start-up\/goliver-reparer-le-foie-sans-greffe_648605<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>03\/2019: GoLiver Therapeutics at BIO-Europe Spring. TH NGUYEN contributed to a roundtable session entitled \u201cWhat\u2019s NEXT in NASH?<br \/>\n\u279e<a href=\"https:\/\/www.labiotech.eu\/in-depth\/nash-treatment\/\">https:\/\/www.labiotech.eu\/in-depth\/nash-treatment\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>02\/2019: France Tech Transfer Invest (FFTI) Tech Tour winner<br \/>\n\u279e<a href=\"https:\/\/www.atlanpole.fr\/actualites\/goliver-therapeutics-laureat-biotech-de-la-france-tech-transfer-invest-2019\/\">https:\/\/www.atlanpole.fr\/actualites\/goliver-therapeutics-laureat-biotech-de-la-france-tech-transfer-invest-2019\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>12\/2018: European Union (ERDF) funding of \u20ac400,000 to develop the first stages of bioproduction process industrialization (2018-2020).<\/p>\n<p>&nbsp;<\/p>\n<p>08\/2018: GoLiver Therapeutics Receives a Positive Scientific Advice from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) on its Biomanufacturing Strategy for Acute Liver Failure<\/p>\n<p>&nbsp;<\/p>\n<p>05\/2018: Published paper. Garnier D, et al. Nguyen TH. Expansion of human primary hepatocytes in vitro through their amplification as liver progenitors in a 3D organoid system. Sci Rep. 2018 May 29;8(1):8222.<br \/>\n\u279e<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29844473\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29844473\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>01\/2018: Forum Atlanpole award (<a href=\"https:\/\/www.lejournaldesentreprises.com\/loire-atlantique-vendee\/breve\/goliver-therapeutics-la-start-coup-de-coeur-du-forum-atlanpole-114098\">https:\/\/www.lejournaldesentreprises.com\/loire-atlantique-vendee\/breve\/goliver-therapeutics-la-start-coup-de-coeur-du-forum-atlanpole-114098<\/a>) <a href=\"https:\/\/www.youtube.com\/watch?v=gAXCBni7OuQ&amp;t=11s\">View video<\/a><br \/>\n\u279e FORUM ATLANPOLE : EFFERVESCENCE, ENERGIE, AMBITION , r\u00e9dig\u00e9 par Atlanpole -&gt; <a href=\"https:\/\/www.atlanpole.fr\/actualites\/forum-atlanpole-effervescence-energie-ambition\/\">View link<\/a><br \/>\n\u279e Bioth\u00e9rapie : une start-up issue d\u2019un laboratoire de l\u2019Universit\u00e9 de Nantes prim\u00e9e, r\u00e9dig\u00e9 par SFR Bonamy -&gt;<a href=\"http:\/\/www.sfrsante.univ-nantes.fr\/accueil\/la-recherche-en-sante-pour-tous\/biotherapie-une-start-up-issue-d-un-laboratoire-de-l-universite-de-nantes-primee-2177179.kjsp\">View link<\/a><br \/>\n\u279e Goliver Therapeutics, la start-up coup de coeur du forum Atlanpole, r\u00e9dig\u00e9 par Le journal des Entreprises -&gt; <a href=\"https:\/\/www.lejournaldesentreprises.com\/loire-atlantique-vendee\/breve\/goliver-therapeutics-la-start-coup-de-coeur-du-forum-atlanpole-114098\">View link<\/a><br \/>\n\u279e Bioth\u00e9rapie. Goliver s\u2019attaque \u00e0 la r\u00e9g\u00e9n\u00e9rescence du foie sans greffe \u00e0 Nantes, r\u00e9dig\u00e9 par Ouest France -&gt; <a href=\"https:\/\/www.ouest-france.fr\/economie\/entreprises\/biotherapie-goliver-s-attaque-la-regenerence-du-foie-sans-transplantation-5503252\">View link<\/a><br \/>\n\u279e Innovation. Chez Atlanpole, les start-up suivies ont un taux de survie de 89 %, r\u00e9dig\u00e9 par Ouest France -&gt; <a href=\"https:\/\/www.ouest-france.fr\/economie\/entreprises\/innovation-chez-atlanpole-les-start-suivies-ont-un-taux-de-survie-de-89-5503262\">View link<\/a><br \/>\n\u279e 5 entreprises innovantes \u00e0 suivre en 2018, r\u00e9dig\u00e9 par Nantes M\u00e9tropole -&gt; <a href=\"https:\/\/www.nantesmetropole.fr\/actualite\/l-actualite-thematique\/5-entreprises-innovantes-a-suivre-en-2018-enseignement-et-recherche-97040.kjsp\">View link<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>01\/2018: Published paper. Kilens S, et al. Parallel derivation of isogenic human primed and naive induced pluripotent stem cells. Nat Commun. 2018 Jan 24;9(1):360.<br \/>\n\u279e<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29367672\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29367672\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>04\/2017: Creation of GoLiver Therapeutics \u2013 Greffe du Tribunal de Commerce de NANTES<br \/>\n-&gt; <a href=\"https:\/\/www.infogreffe.fr\/entreprise-societe\/829253806-goliver-therapeutics-440117B012670000.html?typeProduitOnglet=EXTRAIT&amp;afficherretour=false\">View link<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>07\/2016: Grand Prize -I-Lab start-up innovation contest award<br \/>\n\u279e i-LAB 2016 -Les 5 Grands prix : Tuan Huy Nguyen \u2013 GOLIVER, r\u00e9dig\u00e9 par Minis\u00e8re Enseignement sup\u00e9rieur, Recherche et Innovation -&gt; <a href=\"http:\/\/www.dailymotion.com\/video\/x4kbuh4\">View link<\/a><br \/>\n\u279e 56 laur\u00e9ats et 5 grands prix pour le concours i-LAB 2016 | Bpifrance, r\u00e9dig\u00e9 par BPI France -&gt; <a href=\"http:\/\/www.bpifrance.fr\/A-la-une\/Actualites\/56-laureats-et-5-grands-prix-pour-le-concours-i-LAB-2016-27368\">View link<\/a><br \/>\n\u279e C\u2019est le premier grand prix du concours i-Lab d\u00e9cern\u00e9 \u00e0 une start-up de la r\u00e9gion Pays de la Loire, r\u00e9dig\u00e9 par Atlanpole -&gt; <a href=\"https:\/\/www.atlanpole.fr\/actualites\/goliver-grand-prix-concours-i-lab-2016\/\">View link<\/a><br \/>\n\u279e Goliver, Grand prix du concours i-Lab 2016, r\u00e9dig\u00e9 par Atlanpole -&gt; <a href=\"http:\/\/www.atlanpolebiotherapies.com\/actualites\/goliver\/\">View link<\/a><br \/>\n\u279e Concours i-LAB Parmi les 5 grands prix du Concours i-LAB, 4 ont \u00e9t\u00e9 matur\u00e9s dans une SATT -&gt; <a href=\"http:\/\/www.satt.fr\/i-lab-2016\/\">View link<\/a><br \/>\n\u279e Palmar\u00e8s du concours I-LAB 2016, r\u00e9dig\u00e9 par Biotech.info -&gt; <a href=\"http:\/\/www.biotechinfo.fr\/palmares-des-laureats-du-concours-i-lab-2016\/\">View link<\/a><br \/>\n\u279e GoLiver, prim\u00e9 d\u2019un Grand Prix au concours i-LAB 2016, propose des solutions th\u00e9rapeutiques innovantes pour le traitement des maladies du foie -&gt; <a href=\"https:\/\/www.curie.asso.fr\/i-LAB-2-3-Universite-de-Nantes-Inserm-Ouest-Valorisation.html\">View link<\/a><br \/>\n\u279e 56 laur\u00e9ats et 5 grands prix pour le concours i-LAB 2016 \u2013 12\/07\/2016, r\u00e9dig\u00e9 par La d\u00e9p\u00eache -&gt; <a href=\"https:\/\/www.ladepeche.fr\/article\/2016\/07\/12\/2555170-56-laureats-5-grands-prix-concours-i-lab-2016-2016.html\">View link<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>04\/2016: Start West award<br \/>\n\u279e <a href=\"https:\/\/www.start-west.com\/a-propos\/bilan-2016\/\">https:\/\/www.start-west.com\/a-propos\/bilan-2016\/<\/a><br \/>\n\u279e Le 18h Eco : Goliver ou la naissance d\u2019une start-up sur Orange Vid\u00e9os, r\u00e9dig\u00e9 par T\u00e9l\u00e9nantes -&gt; <a href=\"https:\/\/www.youtube.com\/watch?v=aoWjYjrbumE\">View link<\/a><br \/>\n\u279e Cinq start-up qui vont plaire aux investisseurs, r\u00e9dig\u00e9 par Capital -&gt; <a href=\"https:\/\/www.capital.fr\/entreprises-marches\/cinq-start-up-qui-vont-plaire-aux-investisseurs-1113971\">View link<\/a><br \/>\n\u279e Innovation \u2013 5 p\u00e9pites distingu\u00e9es \u00e0 Start West \u2013 Agence API, r\u00e9dig\u00e9 par API -Region Bretagne \u2013 Pays de la Loire -&gt; <a href=\"https:\/\/www.agence-api.fr\/article\/innovation-a-5-pacpites-distinguaces-a-start-west\">View link<\/a><br \/>\n\u279e GoLiver, laur\u00e9at du concours Start West, r\u00e9dig\u00e9 par Progreffe -&gt; <a href=\"http:\/\/www.progreffe.com\/wp-content\/uploads\/sites\/3\/2016\/07\/lettre-progreffe-n14.pdf\">View link<\/a><br \/>\n\u279e R\u00e9gion_Bretagne \u2013 Les laur\u00e9ats bretons de Start West 2016, r\u00e9dig\u00e9 par Region Bretagne -&gt; <a href=\"http:\/\/www.bretagne.bzh\/jcms\/prod_325215\/fr\/les-laureats-bretons-de-start-west-2016\">View link<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>12\/2015: Published paper. Tolosa L, Caron J, Hannoun Z, Antoni M, L\u00f3pez S, Burks D, Castell JV, Weber A, Gomez-Lechon MJ, Dubart-Kupperschmitt A. Transplantation of hESC-derived hepatocytes protects mice from liver injury. Stem Cell Res Ther. 2015 Dec 12;6:246.<br \/>\n\u279e <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26652177\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26652177\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>07\/2015: I-Lab \u00ab \u00e9mergence \u00bb start-up innovation contest award -&gt; <a href=\"http:\/\/www.enseignementsup-recherche.gouv.fr\/cid90838\/i-lab-2015-remise-des-prix-le-1er-juillet-2015.html\">View link<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>12\/2011 : FP7-EU Innovaliv project \u2013 Innovative strategies to generate human hepatocytes for treatment of metabolic Liver diseases: Tools for personalized cell therapy, r\u00e9dig\u00e9 par Europe<br \/>\n-&gt; <a href=\"https:\/\/cordis.europa.eu\/project\/rcn\/102127_en.html\">View link<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>02\/2009 : FP7 -EU LIV-ES project \u2013 Lancement de LIV-ES, un projet de recherche europ\u00e9en visant \u00e0 d\u00e9velopper des th\u00e9rapies innovantes pour les maladies associ\u00e9es au foie, r\u00e9dig\u00e9 par Europe<br \/>\n-&gt; <a href=\"https:\/\/cordis.europa.eu\/news\/rcn\/118869_es.html\">View link<\/a><\/p>\n<div id=\"gtx-trans\" style=\"position: absolute; left: 6px; top: 70.6667px;\">\n<div class=\"gtx-trans-icon\"><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>03\/2021: GOLIVER THERAPEUTICS IS THE WINNER OF THE FRENCH GOVERNMENT\u2019S \u00ab RECOVERY PLAN FOR INDUSTRY &#8211; STRATEGIC SECTORS \u00bb CALL FOR THE IMPLEMENTATION OF\u00a0 ITS INDUSTRIAL MANUFACTURING PLATFORM PROJECT AIMED AT\u00a0 DEVELOPING BIOMEDICINE FROM PLURIPOTENT STEM CELLS \u279e Press communication : GoLiver_CP_Subvention_France_Relance_20210318 EN.pdf \u279e https:\/\/www.latribune.fr\/entreprises-finance\/industrie\/chimie-pharmacie\/therapie-cellulaire-goliver-therapeutics-sur-les-traces-de-l-arn-messager-880289.html \u279e https:\/\/www.lesechos.fr\/pme-regions\/innovateurs\/goliver-parie-sur-les-cellules-souches-pour-reparer-le-foie-1299316 \u279e https:\/\/nantes.maville.com\/actu\/actudet_&#8211;medecine-regenerative-un-nouveau-pas-de-geant-pour-la-start-up-nantaise-goliver-_fil-4544852_actu.Htm \u279e https:\/\/biotechinfo.fr\/article\/goliver-therapeutics-obtient-un-avis-scientifique-positif-de-lagence-europeenne-du-medicament-ema-sur-sa-strategie-de-developpement-clinique-et-de-bioproduction-dans-linsuffisance\/ &nbsp; 11\/2020: GoLiver Therapeutics\u00a0is [&hellip;]\n","protected":false},"author":1,"featured_media":5011,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/posts\/5170"}],"collection":[{"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/comments?post=5170"}],"version-history":[{"count":5,"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/posts\/5170\/revisions"}],"predecessor-version":[{"id":5222,"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/posts\/5170\/revisions\/5222"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/media\/5011"}],"wp:attachment":[{"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/media?parent=5170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/categories?post=5170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/golivertx.com\/wp-json\/wp\/v2\/tags?post=5170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}